Trial · NCT02478359
Walk On! Physical Activity Coaching
NCT02478359, Not applicable, Completed, Kaiser Permanente; results first posted 2020-02-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Walk On! Physical Activity Coaching. Trials, record NCT02478359. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02478359
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Walk On! Physical Activity Coaching
- NCT number
- NCT02478359
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,707 participants, actual
- Lead sponsor
- Kaiser Permanente
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Physical Activity Coaching (Walk On!)
- First posted
- 2015-06-23
- Last updated
- 2020-02-19
- Results first posted
- 2020-02-19
- Limitations and caveats
It is important to note the low uptake/participation in the Walk On! intervention and its effects on the primary, intention to treat analyses, as well, the sub-optimal baseline and follow-up response rates to the patient-reported outcomes.
Source ClinicalTrials.gov
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Deaths Among Participants | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Participants With All-cause Hospitalizations | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Participants With All-cause Emergency Department Visits | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Participants With All-cause Observation Stays | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays | 12 months following randomization | Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site |
| Secondary | Number of Participants With COPD Exacerbation | 12 months following randomization | COPD exacerbations were ascertained via pharmacy records and utilization data. An outpatient COPD exacerbation will be defined as a care touch (clinic visit, phone, or secure message encounter) with a diagnosis of COPD accompanied by a prescription of either an oral steroid or an antibiotic within 2 days |
| Secondary | COPD Assessment Test, CAT - 12 Months | 12 months | The reported mean change between the baseline and 12 Months scores for the Chronic Obstructive Pulmonary Disease Assessment Test (CAT). Score range is 0-40. A negative change score indicates fewer symptoms. |
| Secondary | Physical Activity | 12 months | Patients were categorized as being: completely inactive (0 mins/week), insufficiently active (1-149 mins/week) or active, meeting national physical activity recommendations (\>150 mins/week) of moderate to vigorous physical activity. |
| Secondary | Personal Health Questionnaire, PHQ8 - 12 Months | 12 months | The reported mean change between the baseline and 12 Months scores. Score range is 0-24. A negative change score indicates less depressive symptoms. |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 registered outcomesOutcomes34
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Deaths Among Participants | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Hospitalizations | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Emergency Department Visits | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All-cause Observation Stays | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays | 12 months following randomization | ITT Population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With COPD Exacerbation | 12 months following randomization | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | COPD Assessment Test, CAT - 12 Months | 12 months | As treated population who completed the survey | score on a scale | MEAN |
| SECONDARY | Physical Activity | 12 months | ITT population | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Personal Health Questionnaire, PHQ8 - 12 Months | 12 months | As treated population who completed the survey | score on a scale | MEAN |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 outcomesResults by group98
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths | Standard Care | 864 | Participants | ||
| Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths | Physical Activity Coaching (Walk On!) | 883 | Participants | ||
| Number of Deaths Among Participants | Standard Care | 117 | Participants | ||
| Number of Deaths Among Participants | Physical Activity Coaching (Walk On!) | 117 | Participants | ||
| Number of Participants With All-cause Hospitalizations | Standard Care | 499 | Participants | ||
| Number of Participants With All-cause Hospitalizations | Physical Activity Coaching (Walk On!) | 502 | Participants | ||
| Number of Participants With All-cause Emergency Department Visits | Standard Care | 694 | Participants | ||
| Number of Participants With All-cause Emergency Department Visits | Physical Activity Coaching (Walk On!) | 702 | Participants | ||
| Number of Participants With All-cause Observation Stays | Standard Care | 269 | Participants | ||
| Number of Participants With All-cause Observation Stays | Physical Activity Coaching (Walk On!) | 295 | Participants |
1 to 10 of 98Source ClinicalTrials.gov
See all 98 results by groupParticipant flow8
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Care | 1,349 | |
| Overall Study | STARTED | Physical Activity Coaching (Walk On!) | 1,358 | |
| Overall Study | Intention-to-treat Population Month 12 | Standard Care | 1,243 | |
| Overall Study | Intention-to-treat Population Month 12 | Physical Activity Coaching (Walk On!) | 1,293 | |
| Overall Study | COMPLETED | Standard Care | 1,243 | |
| Overall Study | COMPLETED | Physical Activity Coaching (Walk On!) | 1,293 | |
| Overall Study | NOT COMPLETED | Standard Care | 106 | |
| Overall Study | NOT COMPLETED | Physical Activity Coaching (Walk On!) | 65 |
Source ClinicalTrials.gov
Adverse events6
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Observational Stays | Investigations | Standard Care | 269 | 1,349 | 269 |
| other | Observational Stays | Investigations | Physical Activity Coaching (Walk On!) | 295 | 1,358 | 295 |
| other | Emergency Department Visits | Investigations | Standard Care | 694 | 1,349 | 694 |
| other | Emergency Department Visits | Investigations | Physical Activity Coaching (Walk On!) | 702 | 1,358 | 702 |
| serious | All-cause hospitalizations | Investigations | Standard Care | 499 | 1,349 | 499 |
| serious | All-cause hospitalizations | Investigations | Physical Activity Coaching (Walk On!) | 502 | 1,358 | 502 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Care | 117 | 1,349 |
| Total, all-cause mortality | Physical Activity Coaching (Walk On!) | 117 | 1,358 |
| Total, other adverse events | Standard Care | 963 | 1,349 |
| Total, other adverse events | Physical Activity Coaching (Walk On!) | 997 | 1,358 |
| Total, serious adverse events | Standard Care | 499 | 1,349 |
| Total, serious adverse events | Physical Activity Coaching (Walk On!) | 502 | 1,358 |
Source ClinicalTrials.gov
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons15
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Observation Stays | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Hospitalizations | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With COPD Exacerbation | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Observation Stays | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Emergency Department Visits | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Hospitalizations | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With All-cause Emergency Department Visits | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays | Trial comparisons |
| Physical Activity Coaching (Walk On!) vs Standard Care: Number of Deaths Among Participants | Trial comparisons |
1 to 10 of 15
See all 15 trial comparisonsTests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02478359
GET https://conductscience.org/api/trials/v1/NCT02478359/registered?page=2